Home›Companies›Food & Agriculture›Verinomics

Verinomics, Inc.

Develops specialty crop varieties for breeders and growers using genomics and gene editing.

Updated Nov 9, 2026·Latest SEC filing Sep 25, 2026·Suggest an edit

About Verinomics

Verinomics is a private company based in New Haven, Connecticut. It has reported $4,776,920 raised in two offerings on Form D since January 2019.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 9, 2026Sep 25, 2026$2,749,997of $12.7M target2$1.3MEquityRule 506(b)Form D ↗
Dec 21, 2018Jan 3, 2019$2,026,923of $3.0M target2$1.0MEquityRule 506(b)Form D ↗
Total, two offerings$4,776,920

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Verinomics's Form D filed Sep 25, 2026.

Stephen Dellaporta
Stephen Dellaporta
Founder and director
Brian Staskawicz
Brian Staskawicz
Co-Founder and Gene Editing Advisor, director
KL

Earlier filings also listed Mat Muller (director, last listed Jan 2019), James Zhu (director, last listed Jan 2019) and Christopher Heffelfinger (executive officer, last listed Jan 2019).

Sources

  1. SECVerinomics, Inc. filing history